|
The Company was originally incorporated as Harbin Renhuang Pharmaceutical Stock Co. Ltd. in 1996 and was reorganized from a closely held limited-liability company to a public limited-liability company in 2001.
2004
Renhuang is named “Outstanding Small Enterprise of Harbin” by the Harbin city government
Renhuang’s project for Ah City Biotech Medicine Park is listed in the supported and tax-advantaged
programsfor the development of Northeastern industry by the National Development and Reform Commission
Renhuang’s process development project of one-step extraction of Lysozyme enzyme is listed in the “National Torch Programs” as a key project for the development of high technology
Renhuang’s Ah City manufacturing facility and Dongfanghong manufacturing facility receive GMP (“Good Manufacturing Practice”) certification
Renhuang establishes the post-doctoral research work station upon government’s approval
2006
Renhuang is reorganized to a new company, Harbin Renhuang Pharmaceutical Co. Ltd.
Renhuang becomes a publicly-traded company in the U.S. through a reverse merger and is quoted on
the OTCBB under the ticker symbol “RHGP”
2007
Renhuang completes the acquisition of Qingyang Herbal Extracting Factory, a manufacturing facility
that processes raw herbal plants into extracts – the intermediate material for Chinese herbal medicine
finished products to expand the Company’s herbal extracting capabilities
Renhuang receives a AAAEnterprise Credit Rating from Chinese Academy of International Trade &
EconomicCooperation (CATEC) of Ministry of Commerce of the People’s Republic of China
2009
Renhuang is awarded the prestigious High-Technology Enterprise certificate (“Certificate”) by the
government of Heilongjiang Province, gaining access to a series of national and local government support
programs, including favorable tax treatment, intellectual property protection, and technical support from the
central and local government.
Back to Home
|